Pericytes in the disease spotlight

H van Splunder, P Villacampa, A Martínez-Romero… - Trends in Cell …, 2024 - cell.com
Pericytes are known as the mural cells in small-caliber vessels that interact closely with the
endothelium. Pericytes play a key role in vasculature formation and homeostasis, and when …

Progression of cerebral amyloid angiopathy: a pathophysiological framework

EA Koemans, JP Chhatwal, SJ van Veluw… - The Lancet …, 2023 - thelancet.com
Cerebral amyloid angiopathy, which is defined by cerebrovascular deposition of amyloid β,
is a common age-related small vessel pathology associated with intracerebral haemorrhage …

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

JS Loh, WQ Mak, LKS Tan, CX Ng, HH Chan… - … and Targeted Therapy, 2024 - nature.com
The human gastrointestinal tract is populated with a diverse microbial community. The vast
genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every …

Nutrition strategies promoting healthy aging: From improvement of cardiovascular and brain health to prevention of age-associated diseases

M Fekete, Z Szarvas, V Fazekas-Pongor, A Feher… - Nutrients, 2022 - mdpi.com
Background: An increasing number of studies suggest that diet plays an important role in
regulating aging processes and modulates the development of the most important age …

Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: Role of tryptophan metabolites generated by gut host-microbiota

A Salminen - Journal of Molecular Medicine, 2023 - Springer
Gut microbiota in interaction with intestinal host tissues influences many brain functions and
microbial dysbiosis has been linked with brain disorders, such as neuropsychiatric …

Blood–brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy

K Lau, R Kotzur, F Richter - Translational neurodegeneration, 2024 - Springer
There is increasing evidence for blood–brain barrier (BBB) alterations in Parkinson's
disease (PD), the second most common neurodegenerative disorder with rapidly rising …

siRNA drug delivery across the blood–brain barrier in Alzheimer's disease

MI Sajid, FS Sheikh, F Anis, N Nasim… - Advanced Drug Delivery …, 2023 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disease with a few FDA-
approved drugs that provide modest symptomatic benefits and only two FDA-approved …

The genetic architecture of biological age in nine human organ systems

J Wen, YE Tian, I Skampardoni, Z Yang, Y Cui… - Nature aging, 2024 - nature.com
Investigating the genetic underpinnings of human aging is essential for unraveling the
etiology of and develo** actionable therapies for chronic diseases. Here, we characterize …

Gain-of-function mutations of TRPV4 acting in endothelial cells drive blood-CNS barrier breakdown and motor neuron degeneration in mice

JM Sullivan, AM Bagnell, J Alevy, EM Avila… - Science translational …, 2024 - science.org
Blood-CNS barrier disruption is a hallmark of numerous neurological disorders, yet whether
barrier breakdown is sufficient to trigger neurodegenerative disease remains unresolved …

Freshwater cyanobacterial toxins, cyanopeptides and neurodegenerative diseases

G Nugumanova, ED Ponomarev, S Askarova… - Toxins, 2023 - mdpi.com
Cyanobacteria produce a wide range of structurally diverse cyanotoxins and bioactive
cyanopeptides in freshwater, marine, and terrestrial ecosystems. The health significance of …